Data from The Cancer Genome Atlas (TCGA) reveal upregulated BCL6B expression in head and neck squamous cell carcinoma, cholangiocarcinoma, clear cell renal carcinoma, hepatocellular carcinoma, gastric cancer, thyroid cancer, and glioblastoma. This evidence concerns the gene BCL6B and gastric cancer.